Epirubicin hydrochloride is a semisynthetic L-arabino derivative of doxorubicin that inhibits Topoisomerase, DNA/RNA synthesis, and Foxp3, reducing regulatory T cell activity. A stereoisomer of doxorubicin, it undergoes β-glucuronidation, mitigating dose-limiting side effects. It is cytotoxic to HeLa cells (ID50 = 9 μM) and has shown efficacy alone or in combination therapies across various cancers, including breast, ovarian, lymphoma, pancreatic, gastric, and colorectal cancers.
Products > ADC Linker, ADC Payload > ADC Payload | Products > ADC Linker, ADC Payload > ADC Payload > Doxorubicin
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.